BUNDESINSTITUT FUER RISIKOBEWERTUNG

Their core work

Germany's Federal Institute for Risk Assessment (BfR) is the government body responsible for scientifically assessing risks to human health from chemicals, food, and consumer products. In H2020, BfR contributes deep expertise in toxicology, chemical exposure modelling, and regulatory risk assessment — particularly for nanomaterials, endocrine disruptors, PFAS, and food contaminants. They bridge the gap between laboratory hazard data and regulatory decision-making, developing test methods and frameworks that shape EU-wide safety standards. Their work directly informs how chemicals and materials are approved, restricted, or banned across Europe.

What they specialise in

How they've shifted over time

In 2014–2018, BfR's H2020 work centred on nanosafety fundamentals — characterising nanomaterials, developing grouping methodologies, and building public awareness (SeeingNano, NanoREG II, NanoCommons). Food safety projects focused on specific contaminants like mycotoxins and food fraud. From 2019 onward, the focus shifted decisively toward integrated risk assessment of complex exposures: chemical mixtures, PFAS, endocrine disruptors, and microplastics — with strong emphasis on New Approach Methodologies (NAMs) and computational toxicology to replace animal testing. The trajectory shows a move from studying individual hazards toward systemic, multi-chemical human health risk frameworks.

BfR is moving toward computational and in vitro methods for assessing complex chemical mixtures and emerging pollutants (PFAS, microplastics), positioning itself at the centre of Europe's next-generation regulatory toxicology.

How they like to work

BfR operates exclusively as a consortium partner — never as coordinator in H2020 — which reflects its role as a regulatory science authority contributing specialist expertise rather than managing projects. With 497 unique partners across 42 countries, they are a highly connected hub in the European risk assessment community. Their consistent participation in large Research and Innovation Actions (20 of 28 projects are RIA) shows they are sought after for their regulatory credibility and laboratory capabilities in major multi-partner consortia.

BfR has collaborated with 497 unique partners across 42 countries, making it one of the most broadly connected risk assessment institutes in Europe. Their network spans EU member states and extends globally, notably including China (EU-China-Safe) and non-EU countries through One Health and food safety initiatives.

What sets them apart

BfR is Germany's federal authority for consumer health protection — not a university lab or private consultancy, but the institution whose scientific opinions directly shape German and EU regulation. This gives any consortium instant regulatory credibility and access to real-world risk assessment workflows. For partners seeking to move research results toward market approval or regulatory acceptance, BfR provides the bridge between scientific findings and policy implementation that few other organisations can offer.

Highlights from their portfolio

• One Health EJP
  By far their largest project (EUR 3.4M) and a flagship European Joint Programme linking food safety, antimicrobial resistance, and zoonoses under one integrated framework.
• RISK-HUNT3R
  EUR 812K project developing next-generation human-centric testing strategies — central to the EU's push to replace animal testing in chemical risk assessment.
• PANORAMIX
  Addresses one of the most pressing regulatory challenges: assessing real-life chemical mixtures rather than individual substances, combining bioassays with computational mixture modelling.